Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,131.20
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,282.84
(
-0.75%
)
News Focus
News Focus

Replies to post #143370 on Biotech Values

Replies to #143370 on Biotech Values
icon url

biomaven0

06/06/12 12:21 PM

#143371 RE: DewDiligence #143370

Approximately how far behind Tofacitinib is INCY/LLY’s RA drug?



LLY hasn't yet started their Phase III. Analysts are projecting somewhere around the 2015 time frame for approval.

Peter